Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2025-12-24 @ 9:19 PM
NCT ID:
NCT02860104
Eligibility Criteria:
Inclusion Criteria:
* breast lesion proved by using core-needle biopsy;
* for benign lesions,lesion 1.0 cm or larger in greatest diameter and continually increasing during a half year follow-up; for malignant ones, lesion size 2cm or smaller;
* distance of at least 1.0cm to papilla with the patients supine;
* the symptoms of local pain, discomfortable or compression considered probably relating to the lesion of breast;
* the patient with evidently psychological pressure due to the occurrence of the lesion;
* patients unwilling or refused to receive other treatment and presence of an appropriate route for percutaneous puncture under US guidance.
Exclusion Criteria:
* patients who were pregnant or breast-feeding;
* patients with evidence of coagulopathy or acute or severe pulmonary insufficiency or heart dysfunction;
* patients during menstrual period;
* patients who wanted to undergo other therapies including surgical excision and vacuum-assisted biopsy.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02860104
Study Brief:
Protocol Section:
NCT02860104